MTZ NYSE Week ended 31 Jul 2026

Weekly Investor Report

MasTec Inc · Industrials · Engineering & Construction

Open interactive chart View report data
Latest close 263.1 USD
-22.1% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -20.1% below the Trend Line and sits at 34.9% of its 52-week range. The latest completed week returned -22.1%, after a -29.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers. Options positioning is volatility with 57/100 conviction, while the latest news-sentiment score is 54/100.

Setup score 35 out of 100
Latest Close 263.1 USD 31 Jul 2026
1W Return -22.1% latest completed week
4W Return -29.5% short-term follow-through
12W Return -36.5% quarterly tape
Trend Breadth 98.1% 51 of 52 weeks active
Volume Ratio 1.7x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Volume is elevated versus the 13-week average, confirming attention.
  • Next-week expectancy is positive at 55.43% based on similar historical setup states.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • 9 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -22.1% Latest completed week; four-week move -29.5%. Indicator stack 54/15 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 55.43% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 57/100 conviction; expected move 23.2%. News sentiment 54/100 66 relevant articles in the latest sentiment read. Event risk 30 Jul Latest stored earnings date was 30 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -20.1% below the Trend Line and sits at 34.9% of its 52-week range. The latest completed week returned -22.1%, after a -29.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6812-week average 0.91

12-week confirmation

Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.68Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers99 reversal markers

No recent accumulation markers. 9 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -29.5% over four weeks, -36.5% over 12 weeks, and 51.2% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-22.1%
4W-29.5%
12W-36.5%
26W9.4%
52W51.2%
Active trend streak0 weeks
Active weeks in one year51
Trend breadth98.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.87Latest activity-pressure read.
Pressure change-242.2%Four-week change in activity pressure.
Leadership-11.27Latest relative-leadership reading.
RS change-137.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength18/100Blend of value, momentum, and quality. Underlying universe rank 83; rank 1 is best.
Value5/100Relative valuation strength. Underlying universe rank 96; rank 1 is best.
Quality35/100Profitability and accounting quality. Underlying universe rank 66; rank 1 is best.
Momentum93/100Medium-term price momentum. Underlying universe rank 8; rank 1 is best.
Growth91/100Revenue and earnings growth. Underlying universe rank 10; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework18/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
58.2x
Price divided by trailing earnings.
Price / sales
1.7x
Market value relative to trailing revenue.
EV / EBITDA
26.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
3.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
11.3%
Gross profit retained from each unit of revenue.
Operating margin
5.1%
Operating profit retained from revenue.
Free-cash-flow margin
5.7%
Free cash flow generated from revenue.
Return on invested capital
11.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
22.6%
Latest one-year revenue growth.
EPS growth
114.5%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-30.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.2%
Net share repurchases relative to market value.
Shareholder yield
0.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

MTZ shows volatility options pressure with a 57/100 conviction score, put-call volume ratio of 0.17, expected move of 23.2%, and Sharemaestro trend signal active.

Conviction57/100
Expected move23.2%
Put/call volume0.17
Pressure77
Speculation49
Volatility87
Trend agreement21
Open options detail
Insider activity12 / 7

12 acquisitions and 7 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 66 relevant articles.

21 positive · 38 neutral · 7 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings30 JulLatest stored earnings date was 30 Jul 2026.
Options expected move23.2%Nearest-chain priced movement where available.
52-week drawdown-40.4%Distance below the 52-week high.
13-week volatility7.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher16 of 2610 weeks finished lower.
Best week+11.0%Week of 1 May.
Worst week-22.1%Week of 31 Jul.
Latest week-22.1%Week of 31 Jul.

Shape of recent returns

Strong gains10
Modest gains6
Flat weeks0
Modest losses5
Sharp losses5
Recent vol7.1%13-week weekly-return volatility.
Base vol5.7%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew4.4% / -4.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape41/100

Trend, activity pressure, participation, and risk combine to a 41/100 tape read.

 Indicator analysis63/100

Latest 12-week confirmation: trend 11/12, activity pressure 6/12, relative leadership 11/12.

Activity pressure 0.68; 9 reversal markers Next-Week ExpectancyPositive 55.43%

Next-week expectancy is positive with a 55.43% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors35/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 39 SVQF18/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 829.0 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options43/100

MTZ shows volatility options pressure with a 57/100 conviction score, put-call volume ratio of 0.17, expected move of 23.2%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 23.2% Sentiment54/100

Weighted news tone is neutral across 66 relevant articles.

MasTec, Inc. Stock 12‑Month Price Target Cut to $487, Implies 50% Upside Insiders12 / 7

12 acquisitions and 7 disposals in the latest 180-day insider tape.

 Earnings30 Jul

Latest stored earnings date was 30 Jul 2026.

 Research flow1 items

1 recent research articles and 0 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026263.1 USD-22.1%329.2 USD165.8 USD-0.87-11.2710.5MOff
24 Jul 2026337.8 USD2.5%328.1 USD164.8 USD-0.8015.574.2MOn
17 Jul 2026329.6 USD-11.6%324.3 USD163.4 USD-0.4512.987.9MOn
10 Jul 2026372.9 USD-0.1%320.6 USD162.0 USD-0.3826.825.2MOn
3 Jul 2026373.4 USD-5.8%315.5 USD160.3 USD-0.2530.145.2MOn
26 Jun 2026396.2 USD4.4%310.4 USD158.7 USD-0.1142.677.5MOn
19 Jun 2026379.7 USD4.6%304.3 USD156.9 USD0.0735.234.1MOn
12 Jun 2026363.0 USD-0.3%298.1 USD155.2 USD0.4432.045.4MOn
5 Jun 2026363.9 USD-3.8%292.4 USD153.5 USD1.0334.635.2MOn
29 May 2026378.4 USD-1.0%286.9 USD151.9 USD1.5838.057.6MOn
22 May 2026382.1 USD-7.9%281.1 USD150.2 USD1.9643.215.1MOn
15 May 2026414.9 USD0.1%275.5 USD148.4 USD2.1958.975.5MOn
8 May 2026414.3 USD-0.7%268.4 USD146.3 USD2.1361.654.9MOn
1 May 2026417.4 USD11.0%261.1 USD144.3 USD2.0369.476.4MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.